Yajun Geng

706 total citations
21 papers, 446 citations indexed

About

Yajun Geng is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Yajun Geng has authored 21 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Yajun Geng's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Immune Cell Function and Interaction (4 papers). Yajun Geng is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Immune Cell Function and Interaction (4 papers). Yajun Geng collaborates with scholars based in China, United States and Lebanon. Yajun Geng's co-authors include Xianghong Luan, Yanmin Zhou, Smit Dangaria, Gokul Gopinathan, Qi Li, Shunli Chu, Antonia Kolokythas, Yingbin Liu, Gnanasekar Munirathinam and Maolan Li and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Hepatology.

In The Last Decade

Yajun Geng

21 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yajun Geng China	14	156	113	96	89	77	21	446
Sarah Volk United States	10	91 0.6×	102 0.9×	17 0.2×	79 0.9×	54 0.7×	16	384
Cristiane Ribeiro Salmon Brazil	14	85 0.5×	256 2.3×	28 0.3×	38 0.4×	54 0.7×	28	558
Reiko Yashiro Japan	8	93 0.6×	138 1.2×	51 0.5×	28 0.3×	45 0.6×	9	347
Hirohito Mitsuyama Japan	9	115 0.7×	106 0.9×	34 0.4×	137 1.5×	50 0.6×	9	490
Khalid Al Hezaimi Saudi Arabia	8	56 0.4×	181 1.6×	41 0.4×	56 0.6×	46 0.6×	13	380
Sijia Na China	9	93 0.6×	119 1.1×	25 0.3×	57 0.6×	38 0.5×	23	358
Marta Miyazawa Brazil	11	193 1.2×	288 2.5×	36 0.4×	151 1.7×	140 1.8×	21	799
Kanako J. Nagatomo United States	8	222 1.4×	203 1.8×	20 0.2×	59 0.7×	30 0.4×	9	561
Yuk‐Kwan Chen Taiwan	13	47 0.3×	178 1.6×	18 0.2×	148 1.7×	89 1.2×	21	593

Countries citing papers authored by Yajun Geng

Since Specialization

Citations

This map shows the geographic impact of Yajun Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajun Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajun Geng more than expected).

Fields of papers citing papers by Yajun Geng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajun Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajun Geng. The network helps show where Yajun Geng may publish in the future.

Co-authorship network of co-authors of Yajun Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Yajun Geng. A scholar is included among the top collaborators of Yajun Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajun Geng. Yajun Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Weijian, Lu Zou, Shuai Huang, et al.. (2024). The anticancer activity of bile acids in drug discovery and development. Frontiers in Pharmacology. 15. 1362382–1362382. 6 indexed citations

Yang, Jiahua, Xuechuan Li, Shili Chen, et al.. (2024). GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2–STAT3 pathway. Cancer Letters. 598. 217067–217067. 5 indexed citations

Liu, Shujie, Weijian Li, Jun Chen, et al.. (2024). The footprint of gut microbiota in gallbladder cancer: a mechanistic review. Frontiers in Cellular and Infection Microbiology. 14. 1374238–1374238. 7 indexed citations

Yang, Yang, Huaifeng Li, Ke Liu, et al.. (2024). Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis. Journal of Translational Medicine. 22(1). 299–299. 4 indexed citations

Zheng, Guoxing, et al.. (2023). Complete Tolerogenic Adjuvant Stimulates Regulatory T Cell Response to Immunization. The Journal of Immunology. 210(5). 609–617. 3 indexed citations

Li, Yang, Bo Yang, Huijie Miao, et al.. (2023). Nicotinamide N-methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma. Hepatology. Publish Ahead of Print(5). 1352–1367. 22 indexed citations

Wang, Ziyi, Shijia Wang, Yunping Hu, et al.. (2023). YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer. Cancer Letters. 563. 216184–216184. 36 indexed citations

He, Min, et al.. (2023). SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress. Cell Cycle. 22(19). 2130–2141. 2 indexed citations

Jiang, Chengkai, Yang Li, Yongsheng Li, et al.. (2022). Fibrinogen promotes gallbladder cancer cell metastasis and extravasation by inducing ICAM1 expression. Medical Oncology. 40(1). 10–10. 19 indexed citations

10.

Zou, Lu, Yang Yang, Weijian Li, et al.. (2022). tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L. Cellular & Molecular Biology Letters. 27(1). 99–99. 15 indexed citations

11.

Li, Lin, Tai Ren, Ke Liu, et al.. (2021). Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Frontiers in Oncology. 11. 692647–692647. 18 indexed citations

12.

Geng, Yajun, et al.. (2020). HMGB1-Neutralizing IgM Antibody Is a Normal Component of Blood Plasma. The Journal of Immunology. 205(2). 407–413. 8 indexed citations

13.

Ren, Jianjun, et al.. (2017). Modified laparoscopic cholecystectomy technique for treatment of situs inversus totalis: A case report. Journal of International Medical Research. 45(3). 1261–1267. 16 indexed citations

14.

Pan, Yue, Hanzhong Ke, Zhaoqi Yan, et al.. (2016). The western-type diet induces anti-HMGB1 autoimmunity in Apoe −/− mice. Atherosclerosis. 251. 31–38. 15 indexed citations

15.

Li, Qi, David Reed, Min Liu, et al.. (2014). Lyophilized Platelet-Rich Fibrin (PRF) Promotes Craniofacial Bone Regeneration through Runx2. International Journal of Molecular Sciences. 15(5). 8509–8525. 63 indexed citations

16.

Ma, Jian, et al.. (2013). In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002. Clinics and Research in Hepatology and Gastroenterology. 38(1). 73–80. 19 indexed citations

17.

Zhu, Mingguang, Guoyue Lv, Yajun Geng, et al.. (2013). Overexpression of Ras Homologous C (RhoC) Induces Malignant Transformation of Hepatocytes In Vitro and in Nude Mouse Xenografts. PLoS ONE. 8(1). e54493–e54493. 22 indexed citations

18.

Li, Qi, Smit Dangaria, Gokul Gopinathan, et al.. (2013). Platelet-Rich Fibrin Promotes Periodontal Regeneration and Enhances Alveolar Bone Augmentation. BioMed Research International. 2013. 1–13. 112 indexed citations

19.

Chou, Sharon H., Aditya Shetty, Yajun Geng, et al.. (2012). Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity. Cancer Immunology Immunotherapy. 62(3). 597–603. 14 indexed citations

20.

Zheng, Guoxing, Yajun Geng, Gnanasekar Munirathinam, et al.. (2012). Dexamethasone promotes tolerance in vivo by enriching CD11c^loCD40^lo tolerogenic macrophages. European Journal of Immunology. 43(1). 219–227. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact